Drawing for TRANSFORM DIABETES CARE

USPTO serial 87266941

TRANSFORM DIABETES CARE

Reviewed by CopyMark Law Group

Reg. 5509284Status 705Registered
Filing date
Status date
Registration date
Jul 3, 2018
Examiner
RICHARDS, LESLIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with TRANSFORM DIABETES CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

Erich G. Rhynhart CVS Pharmacy, Inc.Mail Code: 1160One CVS DriveWoonsocket, RI 02895-6195

Goods and services

ClassDescriptionStatusFirst use
035[ Retail pharmacy services; mail order of pharmaceuticals; specialty pharmaceutical distributorship services, namely, distributorships featuring pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; pharmaceutical utilization review services; prescription drug formulary cost and business management services, namely, clinical and cost-effectiveness reviews following evidence-based medicine and incorporation of value-based criteria into formulary designs; Business administration of pharmacy reimbursement programs and services ]SECTION 8 - CANCELLEDDec 13, 2016
036[ Pharmacy benefit management services; insurance claims processing of pharmaceutical benefits; Financial administration of pharmacy reimbursement programs and services ]SECTION 8 - CANCELLEDDec 13, 2016
044Therapeutic pharmaceutical services, namely, dispensing of pharmaceuticals and counseling on medications, incorporating disease monitoring services and clinical reviews; Pharmaceutical advice; disease management programsACTIVEDec 13, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 2, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 2, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 21, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jul 3, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 25, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 9, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 8, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 18, 2018IUAFUSE AMENDMENT FILED—
Apr 18, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 24, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 29, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jul 19, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 19, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 19, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 27, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2017CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jan 12, 2017ALIEASSIGNED TO LIE—
Jan 12, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 12, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 12, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 5, 2017DOCKASSIGNED TO EXAMINER—
Dec 19, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance